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INTRODUCTION
For some common cancers (including lung, 
colorectal, and breast cancer), survival in the 
UK is lower than in comparable high-income 
countries.1 It is thought that this is due 
largely to later-stage disease at diagnosis 
in the UK. This may be partly related to 
system delays following presentation, 
some of which have increased over the last 
decade in England;2 it may also arise from 
low symptom awareness, negative beliefs 
about cancer, and reluctance to ‘waste the 
doctor’s time’3,4 — all of which could extend 
the patient interval.5 There is a positive 
association between levels of awareness 
of cancer and survival.6 In addition, there 
remain geographic and socioeconomic 
inequalities in cancer survival, although 
the gap has narrowed somewhat in recent 
years.7,8
Several campaigns, including Be Clear 
on Cancer, have aimed to raise the level of 
symptom awareness and encourage help 
seeking for symptoms.9 Some have shown 
encouraging results with respect to diagnosis 
of cancer at an earlier stage;10,11 others have 
shown an increase in consultations and 
referrals, but no effect on cancer diagnoses 
or the stage of disease at diagnosis.12 This 
gives rise to the concern that population-
level, mass-media campaigns may increase 
consultations among the ‘worried well’, 
rather than reaching the population most in 
need of earlier presentation.
This concern led to speculation that 
targeted, rather than whole-population, 
symptom-awareness interventions might 
be more effective at reducing the patient 
interval and improving the disease stage at 
symptomatic presentation. Targeting, in this 
context, is at those whose circumstances 
or lifestyle imply that, should they develop 
cancer, they will be at increased risk of being 
diagnosed at a later stage in the disease 
trajectory. This population includes: those 
of lower socioeconomic status, smokers, 
those with chronic comorbidities, certain 
ethnic groups, and those who tend to use 




For some common cancers, survival is lower in 
the UK than in comparable high-income countries. 
Aim
To assess the effectiveness of a targeted postal 
intervention (to promote awareness of cancer 
symptoms and earlier help seeking) on patient 
consultation rates.
Design and setting
A two-arm randomised controlled trial was carried 
out on patients aged 50-84 years registered at 
23 general practices in rural and urban areas of 
Greater London, Greater Manchester, and the 
North East of England.
Method
Patients who had not had a consultation at their 
general practice in the previous 12 months 
and had at least two other risk factors for late 
presentation with cancer were randomised to 
intervention and control arms. The intervention 
consisted of a posted letter and leaflet. Primary 
outcome was the number of consultations at 
the practice with patients randomised to each 
arm in the 6 months subsequent to posting the 
intervention. All patients with outcome data were 
included in the intention-to-treat analyses. 
Results
In total, 1513 patients were individually 
randomised to the intervention (n = 783) and 
control (n = 730) arms between Nov 2016 — May 
2017; outcome data were available for 749 and 
705 patients, respectively, with a statistically 
significantly higher rate of consultation in the 
intervention arm compared with the control arm: 
436 versus 335 consultations (relative risk 1.40, 
95% confidence interval = 1.11 to 1.77, P = 0.004). 
There was, however, no difference in the numbers 
of patients consulting.
Conclusion
Targeted interventions of this nature can change 
behaviour; there is a need to develop interventions 
that can be more effective at engaging patients 
with primary care. This study demonstrates that 
targeted interventions promoting both awareness 
of possible cancer symptoms and earlier health 
seeking, can change behaviour. There is a need to 
develop and test interventions that can be more 
effective at engaging the most at-risk patients. 
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METHOD
Study design and setting
A two-arm randomised controlled trial 
(RCT) — called Writing to Encourage 
Late Consultation Outpatients to Make 
Engagement with their GP (WELCOME-GP) 
— was carried out to test the effectiveness 
of a postal intervention that was targeted 
at certain vulnerable groups and intended 
to promote awareness of cancer symptoms 
and earlier help seeking at general practice. 
It was designed to: 
• promote awareness of six cancer ‘red-
flag’ symptoms; and 
• allay fears of wasting the doctor’s time. 
The intervention was targeted at a 
population that had not attended their general 
practice in the previous 12 months, with 
factors that suggest this may be incongruous 
with their clinical need and attributes known 
to be risk factors for late-stage presentation 
of cancer.13–17 A total of 24 practices from 
three areas in England — rural and urban 
areas of the North East, Greater Manchester, 
and Greater London — agreed to take part; 
one practice subsequently withdrew.
Sample and randomisation
Patients were eligible for inclusion if they: 
• were aged 50–84 years;
• were registered with a participating 
practice;
• had not had a consultation at their registered 
practice in the previous 12 months; and 
satisfied at least two of the following:
—   lower socioeconomic status (in either 
of the two lowest quintiles of the Index 
of Multiple Deprivation 2015, based on 
post code);18
—   missed last scheduled screening for 
breast cancer, bowel cancer, cervical 
cancer, or abdominal aortic aneurism;
—   history of use of emergency or out-
of-hours (OOH) services instead of 
primary care; 
—   missed last appointment for chronic-
disease monitoring/management; 
—   lived alone (indexed by being the only 
person registered with the practice at 
their address) as a marker of social 
isolation; and 
—   smoker (ever). 
Eligibility was assessed from patients’ 
primary care electronic health records. It 
was not possible to identify, with confidence, 
patients who had used emergency or OOH 
services from the practice databases so no 
patients were recruited on this basis.
Persons were ineligible if: 
• they already had a diagnosis of cancer;
• the GP considered recruitment 
inappropriate in view of the patient’s state 
of health or cognitive capacity; or 
• the GP felt that the patient would not wish 
to be included in the research.
Sample-size calculations are described in 
Supplementary Appendix S1. Each practice 
was provided with a computer-generated 
randomisation schedule. Practice staff 
identified eligible patients and randomly 
allocated them to the intervention or to usual 
care; there was no concealment of allocation. 
At the end of the 6-month observation period, 
staff at each practice reported the following 
for each randomised patient:
• the number of consultations by each 
patient who continued to be registered 
throughout the period; 
• the month of the consultation(s);
• the reason for the consultation(s);
• whether any investigations or physical 
examinations were arranged and 
completed; and
• whether referrals to secondary care were 
made. 
De-identified data were stored on 
encrypted databases that remained at 
How this fits in 
Later stage of cancer diagnosis is 
associated with poorer survival, and may 
arise from low symptom awareness and 
delays in presenting to primary care. 
Population-wide campaigns to increase 
awareness and encourage help seeking 
have shown mixed results in terms of stage 
at diagnosis and numbers of primary care 
consultations. This randomised controlled 
trial was targeted at a population whose 
circumstances suggested that, should they 
develop cancer, they would be at increased 
risk of being diagnosed with later-stage 
disease. This study demonstrates that 
targeted interventions of this nature, 
promoting both awareness of cancer 
symptoms and earlier health seeking, can 
change consultation behaviour of those 
who are likely to benefit most from earlier 
symptomatic presentation. However, in 
this study the intervention increased the 
frequency of consultation but not the 
number of persons consulting.
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practices. Intention-to-treat (ITT) analyses 
were carried out by the data analysis team on 
anonymised data for all eligible patients for 
whom data were available at the end of the 
observation period. Due to the nature of the 
intervention, it was necessary that patients 
in both groups were unaware that they were 
taking part in a research study; however, 
it would have been impractical for practice 
staff and the data analysis team to operate 
on this basis so they were not blinded to 
the allocation. Censored, anonymised data 
output was generated from the encrypted 
database at each practice and securely 
transmitted to the research team. 
Intervention
The Model of Pathways to Treatment 
provides a framework for understanding 
the pathways between an individual first 
detecting a bodily change and subsequently 
undergoing treatment,19 beginning with 
‘appraisal’ and ‘help seeking’ intervals. 
Crucially, the individual must believe there to 
be a reason to present with their symptom; 
this is often motivated by heuristics, such as 
concern about a worsening symptom or its 
interference with their daily activities.20 
The present intervention can be 
contextualised within these intervals, in that 
it was intended to: 
• prompt appraisal through symptom 
awareness;
• provide individuals with a ‘cue to action’ for 
visiting their GP; and 
• use messaging to counteract known 
attitudinal barriers to help seeking. 
Furthermore, the personalised, GP-led 
approach drew on the success of primary 
care endorsement in the cancer-screening 
context.21,22
The intervention consisted of a letter (see 
Supplementary Appendix S2), signed by one 
of the GPs at the patient’s practice, noting 
that the recipient had not been seen at the 
practice for some time and reassuring them 
that consulting with any symptoms would 
not be considered wasting the doctor’s time. 
The letter also drew attention to an enclosed 
leaflet (see Supplementary Appendix S3), 
which detailed six symptoms that are 
considered to potentially raise suspicion for 
cancer: 
• blood in urine; 
• blood in stool; 
• persistent cough; 
• haemoptysis; 
• difficulty swallowing; and 
• unexplained weight loss. 
These symptoms were chosen as they 
feature in the National Institute for Health 
and Care Excellence’s recommendations 
for referral for suspected cancer.23 The first 
practice mailed the intervention materials to 
all patients allocated to the intervention arm 
on 11 November 2016, and the last did so on 
31 May 2017.
Outcomes
The primary endpoint was the equivalent 
annual rate of consultations with clinicians 
from the patient’s registered practice in the 
6 months following randomisation (that is, 
the date that letters were mailed), whether 
the consultations were at the practice itself, 
home visits, or telephone consultations. This 
rate was calculated as the total number of 
consultations divided by the total period of 
exposure (half a year per patient; only those 
patients registered at the practice for the 
full 6 months were included in the analysis). 
Secondary endpoints were: 
• total general practice activity — that is, 
consultations, referrals to secondary care, 
completed investigations (for example, 
blood tests) arranged by the practice, 
physical examinations carried out at the 
practice (for example, blood pressure 
check and digital rectal examination), and 
any diagnoses; and 
• the use of emergency and OOH services in 
the study and control groups. 
Randomised, n = 1513
Assigned to
intervention group,
n = 783 
Included in
intention-to-treat
analysis, n = 749
Included in
intention-to-treat
analysis, n = 705
Assigned to
control group,
n = 730 
Present at
baseline, n = 729 
Present at
baseline, n = 781 
Lost to follow-up (ceased
to be registered with GP
before end of study period),
n = 32 
Lost to follow-up (ceased
to be registered with GP
before end of study period),
n = 24 
Excluded, n = 2:
    n = 1, found to be ineligible
    n = 1, intervention not posted
Excluded, n = 1:
    n = 1, found to be duplicate of
    patient in intervention group
Figure 1. WELCOME-GP trial: CONSORT flow diagram.
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As noted above, it could not be established 
with confidence whether patients had made 
use of emergency services, so this particular 
analysis was not possible. It also became 
clear during the course of the study that 
it would not be possible to collect data on 
subsequent diagnoses, as these may have 
occurred some time after the end of the 
6-month follow-up. Several other analyses 
were carried out: the primary and secondary 
analyses were repeated, considering only 
those consultations that had taken place for 
at least one of the six symptoms identified in 
the leaflet; the total number of consultations 
that took place in the same calendar month 
as randomisation (the period immediately 
following the mailing of the intervention) 
were compared between the intervention 
and control groups. 
Statistical analyses
All randomised patients for whom follow-up 
data were available were included in the ITT 
analyses. Data were analysed by zero-inflated 
Poisson regression,24 a technique that takes 
account of the large number of persons with 
no consultations at all during the 6-month 
observation period. Relative risks (RRs) of 
consultation with 95% confidence intervals 
(CIs) were calculated. Robust variance 
estimators were used, allowing for clustering 
by person. Stata (version 15.1) was used for 
data analysis. 
RESULTS
A total of 1513 patients were randomised 
using simple 1:1 randomisation (Figure 1).
Table 1 shows the age, sex, eligibility criteria 
satisfied, and region of residence of the 
patients present at baseline; there were 
no differences between the intervention 
and control arms at a nominal 5% level 
of significance. Of the 1513 randomised, 
1454 (96.1%) (intervention: n = 749, control: 
n = 705) remained at the same practice 
6 months post-randomisation and, therefore, 
had a primary endpoint for analysis.
Statistics
Primary analyses. Table 2 shows general 
practice consultations and onward referrals 
in the two trial arms, and the reasons given 
for consultations. There was a significantly 
higher rate of consultation in the intervention 
arm compared with the control arm (n = 436 
consultations versus n = 335 consultations, 
RR 1.40, 95% CI = 1.11 to 1.77, P = 0.004), 
but no statistically significant difference 
between arms in the likelihood of individuals 
consulting (odds ratio 0.92, 95% CI = 0.72 to 
1.18, P = 0.53). Onward referral rates were 
higher in the intervention arm, but there 
was no statistical significance (n = 85 [19.5% 
of consultations] versus n = 56 [16.7%], 
RR 1.44, 95% CI = 0.97 to 2.14, P = 0.070). 
There was a statistically significant difference 
in the number of clinical investigations and 
physical examinations carried out as a result 
of consultations, with 282 in the intervention 
arm compared with 212 in the control arm 
(RR 1.34, 95% CI  = 1.01 to 1.77, P = 0.041).
Additional analyses. The number of 
consultations for the symptoms described 
in the leaflet was higher in the intervention 
arm (n = 38) than in the control arm (n = 22) 
(Table 2), although this was not statistically 
significant (RR 1.74, 95% CI = 0.81 to 3.74, 
P = 0.16). Onward referral in relation to 
symptoms in the leaflet did not differ by arm 
(n = 8 versus n = 8, RR 0.88, 95% CI = 0.25 to 
3.07, P = 0.84). There were more subsequent 
investigations and examinations in the 
intervention arm for symptoms in the leaflet 
(n = 34 versus n = 19) but this difference was 
also not statistically significant (RR 1.94, 
Table 1. Baseline characteristics of study sample, N = 1510
Factor Intervention, n (%) Control, n (%)
Total sample 781 729
Age, years  
 <50 0 (0.0) 0 (0.0)
 50–59 621 (79.5) 557 (76.4)
 60–69 104 (13.3) 113 (15.5)
 ≥70 56 (7.2) 59 (8.1)
Sex  
 Male 546 (69.9) 500 (68.6)
 Female 235 (30.1) 229 (31.4)
Lower socioeconomic status  
 No 115 (14.7) 118 (16.2)
 Yes 666 (85.3) 611 (83.8)
Missed last screening appointment  
 No / not applicable 565 (72.3) 522 (71.6)
 Yes 216 (27.7) 207 (28.4)
Missed last chronic disease monitoring  
appointment
 No 628 (80.4) 610 (83.7)
 Yes 153 (19.6) 119 (16.3)
Living alone
 No 394 (50.4) 381 (52.3)
 Yes 387 (49.6) 348 (47.7)
Smoker  
 No 84 (10.8) 81 (11.1)
 Yes 697 (89.2) 648 (88.9)
Region  
 North East England 241 (30.9) 221 (30.3)
 Greater Manchester 280 (35.9) 273 (37.4)
 Greater London 260 (33.3) 235 (32.2)
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95% CI = 0.90 to 4.21, P = 0.093). There 
were no statistically significant differences 
between the intervention and control 
arms with regard to the reasons given for 
consultation.
Table 3 shows the number of consultations 
in the calendar month of randomisation and 
in subsequent months. Table 4 shows the 
month in which the first consultation took 
place. There were statistically significantly 
more consultations during the calendar 
month of randomisation in the intervention 
arm (n = 16), than in the control arm (n = 8) 
(Table 4) (RR 2.50, 95% CI = 1.07 to 5.86, 
P = 0.035). However, there was no statistically 
significant difference between the arms, in 
terms of the month of first consultation 
(0.3 months earlier in intervention arm, 
95% CI = –0.7 to 0.1, P = 0.10). Although the 
date of randomisation in each practice was 
known, exact dates of consultations were 
not. Sensitivity analyses determined that the 
date of the month on which randomisation 
occurred did not have any impact on the 
statistical significance of these results.  
DISCUSSION
Summary
This trial took place in a population that was 
interacting less with primary care than most 
of their age-matched peers and had factors 
associated with a lesser tendency to seek 
help and associated with late presentation of 
cancer.13–17,25,26 The results demonstrated that 
a targeted primary care-based intervention 
can change consulting behaviour in this 
population, but not necessarily in the way 
expected: in the intervention group, there 
were statistically significantly more general 
practice consultations than in the control 
group during the 6-month intervention period 
but there was no increase in the number 
of persons consulting. More investigations 
and examinations were carried out in the 
intervention group and this difference was 
statistically significant. There were also more 
referrals in the intervention group compared 
to the control group, although this difference 
was not statistically significant. Given the 
relatively small proportion of the population 
targeted in this trial it is possible that, were 
more primary care providers incentivised 
to deliver such a targeted intervention, this 
might result in statistically and clinically 
significant numbers of increased primary 
care consultations for cancer ‘red-flag’ 
symptoms and referrals.
Table 2. Consultations, reasons for consultation, onward referrals to secondary care, and completed 
clinical investigations and examinations in the intervention and control groups
Consultation measure Intervention, n (%)a Control, n (%)a Statistic (95% CI)a P-value
Persons still registered at end of study 749 705 — —
Persons consulting 165 (22.0) 165 (23.4) ORb 0.92 (0.72 to 1.18) 0.53
Total consultations 436 (1.16/person year) 335 (0.95/person year) RRc 1.40 (1.11 to 1.77) 0.004
Reason for consultation
 Blood in urine 1 (0.2) 0 (0.00) N/A —
 Blood in stool 2 (0.5) 4 (1.2)  0.38 (0.07 to 2.13) 0.27
 Persistent cough 30 (6.9) 15 (4.5) 1.54 (0.62 to 3.82) 0.36
 Haemoptysis 0 (0.00) 0 (0.00) N/A —
 Difficulty swallowing 2 (0.5) 2 (0.6) 0.77 (0.05 to 12.14) 0.85
 Weight loss (unexplained) 3 (0.7) 1 (0.3) 2.31 (0.25 to 21.71) 0.47
 Other 398 (91.3) 313 (93.4) 0.97 (0.92 to 1.03) 0.42
Secondary care referral 85 (19.5) 56 (16.7) 1.44 (0.97 to 2.14) 0.070
Clinical investigations and examinations 282 (64.7) 212 (63.3) 1.34 (1.01 to 1.77) 0.041
aUnless otherwise specified. bLogistic regression. cZero-inflated Poisson regression. Bold text denotes significance at an alpha level of 0.05. NA = not applicable due to insufficient 
data. OR = odds ratio. RR = relative risk. 
Table 3. Number of consultations in each calendar month, post-
randomisation, in the intervention and control groups
Calendar months since   








Total number of consultations 436 335
aPartial month, as randomisation took place on different days of the month in each practice.
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Irrespective of the symptom(s) with 
which patients presented, if the increase 
in consultation rates observed among the 
target patient group in this trial were to 
be sustained, this may result in earlier 
diagnoses of cancer; this is because GPs 
generally enquire about ‘red-flag’ symptoms 
when patients present with other lower-
risk possible cancer symptoms. Increased 
consultation rates also provide GPs with 
an opportunity to: promote primary and 
secondary prevention of cancer and other 
disease by supporting patients to attend 
non-symptomatic screening;27 to manage 
other chronic conditions more effectively; 
and to adopt healthier behaviours through 
initiatives such as Making Every Contact 
Count.28 These are activities that GPs should 
already routinely perform for patients who 
present frequently,29 which may partially 
explain inequalities in outcomes in those 
groups that access services less often.
Strengths and limitations 
There were several strengths to this trial. 
The authors were able to recruit a relatively 
large sample of patients from typically hard-
to-reach groups registered at both inner-
city and rural practices across England, 
which gives confidence that the statistically 
significant difference in the number of 
consultations can be applied to the national 
population. This intervention was also 
relatively cheap and acceptable to most 
practices approached. Finally, the unusual 
design of the study — with no study-specific 
prior informed-consent process — meant 
the trial was not affected by selection bias 
for patients who were most interested in and 
prepared to alter behaviour. 
Although the study was sufficiently powered 
to detect a difference in the number of 
consultations and persons consulting, 
it was not powered to be able to detect 
clinically significant differences in additional 
outcomes such as the number of 
consultations for specific symptoms in the 
leaflet. It was possible for the authors to 
measure attendance at general practice, 
investigations, examinations, and referrals 
to secondary care, but it was not possible to 
determine whether the results pertaining to 
those were due to the intended direct effects 
of the intervention on presenting behaviour, 
or whether clinicians were also affected by 
the intervention.
In addition, the authors were unable to 
assess the duration of effect and the impact 
on clinical end-points as a considerably 
larger study population would have been 
required to achieve sufficient power. Due to 
information-governance considerations, the 
authors were not able to collect outcome 
data that were linked to demographic data 
for stratified or adjusted analyses, which 
would have been underpowered. Such 
data should be collected in future studies 
assessing effects and impact on clinical end-
points should these have sufficient statistical 
power for such analyses.
Another limitation was the concept of 
changing the behaviour of a particularly 
difficult-to-reach group with a single postal 
communication; this proved to be rather 
ambitious. It is not known whether a second 
letter would increase effect or if there 
is a ‘dose response’ to this intervention. 
There are several stages in the process 
of cancer awareness, willingness to seek 
help, referral, and diagnosis; the authors 
considered they were not at the stage of 
sufficient knowledge to assess the impact 
of a psychosocial intervention on cancer 
diagnoses. Furthermore, a major limitation 
of targeted postal awareness interventions 
is that they are less likely to be able to reach 
some of the most vulnerable groups who do 
not have a regular address, such as those 
who are homeless.
Comparison with existing literature
The intervention is only a partial solution to 
the problem of incongruous consultation 
behaviour in primary care particularly 
bearing in mind the pressures on capacity. 
Other studies have explored the feasibility 
and acceptability of targeted in-person health 
checks for improving awareness of cancer 
symptoms,30,31 and will explore impact on 
symptom awareness.32 
The targeted promotion of cancer 
awareness and help seeking for specific 
Table 4. Calendar month since randomisation in which first 
consultations took place, in the intervention and control groups.
Calendar months since   








No consultations within 6 months 584 540
Patients for whom data was available 749 705
aPartial month, as randomisation took place on different days of the month in each practice.
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symptoms may help increase and modify 
help-seeking behaviours, and reduce 
inequity in both access to care and cancer 
survival in a way that mass campaigns may 
not.9
Implications for practice
Similar interventions may have applications 
in mitigating other health inequalities by 
facilitating more equitable access to other 
areas of primary care (such as pharmacies 
and psychological wellbeing services).33,34 
Other applications may include: facilitating 
more equitable access to support for 
health and wellbeing promotion; for the 
primary, secondary, and tertiary prevention 
of disease, such as recent letters advising 
those at increased risk of COVID-19 to 
shield themselves by staying at home;35 and 
signposting recipients to the Every Mind 
Matters website.36
During the COVID-19 pandemic, there 
have been fewer referrals to secondary care 
and fewer diagnoses of cancer. Patients are 
balancing the risks of infection with the 
risks of delayed diagnosis. This need may, 
in part, be addressed through initiatives as 
described here, though such an intervention 
will have to be timed to match re-opening of 
diagnostic services. 
This trial demonstrates the possible 
potential of an inexpensive, targeted, postal 
symptom-awareness intervention for 
altering consultation behaviour and reducing 
barriers to help seeking in general practice. 
There is a need to evolve similar 
interventions with the potential to support 
a wider range of patients (such as those 
who may not be registered with a GP), and 
to explore whether there is a dose response 
to a series of communications or any impact 
on diagnoses. This is particularly relevant in 
the UK given the commitment of the NHS to 
providing equitable care.37
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